Ethnicity and clinical outcome for advanced epithelial ovarian cancer patients treated by standard cisplatin/paclitaxel chemotherapy: A combined analysis of gynecologic oncology group clinical trials

被引：2
|
作者：
Farley, J. H.
Tian, C.
Rose, G. S.
Brown, C. L.
Risinger, J. I.
Maxwell, G. L.
机构：
[1] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[2] Gynecol Oncol Grp, Rosewell Pk, NY USA
[3] Walter Reed Army Med Ctr, Washington, DC 20307 USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[5] Curtis & Elizabeth Anderson Canc Inst, Savannah, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.5573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5573
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
    Wright, Alexi A.
    Bohlke, Kari
    Armstrong, Deborah K.
    Bookman, Michael A.
    Cliby, William A.
    Coleman, Robert L.
    Dizon, Don S.
    Kash, Joseph J.
    Meyer, Larissa A.
    Moore, Kathleen N.
    Olawaiye, Alexander B.
    Oldham, Jessica
    Salani, Ritu
    Sparacio, Dee
    Tew, William P.
    Vergote, Ignace
    Edelson, Mitchell I.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (01) : 3 - 15
  • [22] Relationship between polymorphisms in codon 118 and C8092A in ERCC1 and clinical outcome in optimally resected, stage Iii epithelial ovarian cancer treated with intraperitoneal or intravenous cisplatin and paclitaxel:: A Gynecologic Oncology Group study
    Krivak, T. C.
    Darcy, K. M.
    Tian, C.
    Baysal, B. E.
    Armstrong, D. K.
    Gallion, H. H.
    DeLoia, J. A.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S122 - S122
  • [23] Clinical efficacy and prognosis of chemotherapy regimen of apatinib combined with paclitaxel in the treatment of advanced ovarian cancer
    Qiu, Mochang
    Wu, Jian
    Ye, Xiyong
    Zhang, Qinhua
    Yin, Jiangpin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (01): : 191 - 199
  • [24] Association between reduced BRCA1 expression and survival in patients with sporadic epithelial ovarian cancer treated with intraperitoneal versus intravenous cisplatin and paclitaxel: A Gynecologic Oncology Group study
    Lesnock, J.
    Darcy, K.
    Tian, C.
    Gallion, H.
    DeLoia, J.
    Armstrong, D.
    Thrall, M.
    Krivak, T.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S3 - S4
  • [25] The clinical response of advanced epithelial ovarian cancer patients to neoadjuvant chemotherapy in China
    Yao, K.
    Bian, C.
    Li, L.
    Wu, Y.
    Zhao, X.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (03) : 377 - 380
  • [26] Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: A gynecologic oncology group study
    Winter, William E., III
    Maxwell, G. Larry
    Tian, Chunqiao
    Sundborg, Michael J.
    Rose, G. Scott
    Rose, Peter G.
    Rubin, Stephen C.
    Muggia, Franco
    McGuire, William P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (01) : 83 - 89
  • [27] Paclitaxel, cisplatin and epirubicin (PCE) combination chemotherapy for newly diagnosed patients with advanced epithelial ovarian cancer (AEOC)
    Papadimitriou, C
    Anagnostopoulos, A
    Voulgaris, Z
    Vlahos, G
    Kioses, E
    Akrivos, T
    Dimopoulos, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S238 - S238
  • [28] Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: Preliminary results of a Hellenic Cooperative Oncology Group Study
    Skarlos, DV
    Aravantinos, G
    Kosmidis, P
    Athanassiadis, A
    Stathopoulos, GP
    Pavlidis, N
    Bafaloukos, D
    Karphathios, S
    Papakostas, P
    Bamia, C
    Fountzilas, G
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 57 - 61
  • [29] Timing of initiation of adjuvant chemotherapy after surgery - An analysis of gynecologic oncology group early epithelial ovarian cancer
    Tian, Chunqiao
    Monk, Bradley J.
    Herzog, Thomas
    Bell, James
    Young, Robert
    Chan, John K.
    OBSTETRICS AND GYNECOLOGY, 2007, 109 (04): : 121S - 121S
  • [30] Phase II feasibility study of sequential couplets of cisplatin/topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: A National Cancer Institute of Canada Clinical Trials Group Study
    Hoskins, P
    Eisenhauer, E
    Vergote, I
    Dubuc-Lissoir, J
    Fisher, B
    Grimshaw, R
    Oza, A
    Plante, M
    Stuart, G
    Vermorken, J
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (24) : 4038 - 4044
12345